China FDA Issues Warning To Foreign Firms In Wake Of Heparin Safety Issues
Executive Summary
SHANGHAI - In the wake of the U.S. safety scare related to Baxter Healthcare's heparin, China's State FDA has warned foreign pharmaceutical companies to conduct business only with licensed Chinese companies
You may also be interested in...
You Must Remember This: FDA Hopes Q&A Format For Recalls Will Help Public
FDA press releases for product recalls, corrections and withdrawals will soon share a new standardized template meant to make communication more effective
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011